Literature DB >> 19782720

Cell-penetrating peptides: application in vaccine delivery.

Nicole A Brooks1, Dodie S Pouniotis, Choon-Kit Tang, Vasso Apostolopoulos, Geoffrey A Pietersz.   

Abstract

Recent years have seen a surge in interest in cell-penetrating peptides (CPP) as an efficient means for delivering therapeutic targets into cellular compartments. The cell membrane is impermeable to hydrophilic substances yet linking to CPP can facilitate delivery into cells. Thus the unique translocatory property of CPP ensures they remain an attractive carrier, with the capacity to deliver cargoes in an efficient manner having applications in drug delivery, gene transfer and DNA vaccination. Fundamental for an effective vaccine is the delivery of antigen epitopes to antigen-presenting cells, ensuing processing and presentation and induction of an immune response. Vaccination with proteins or synthetic peptides incorporating CTL epitopes have proven limited due to the failure for exogenous antigens to be presented efficiently to T cells. Linking of antigens to CPP overcomes such obstacles by facilitating cellular uptake, processing and presentation of exogenous antigen for the induction of potent immune responses. This review will encompass the various strategies for the delivery of whole proteins, T cell epitopes and preclinical studies utilizing CPP for cancer vaccines. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782720     DOI: 10.1016/j.bbcan.2009.09.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer.

Authors:  Seyed Mohammad Ali Hosseini Rad; Lida Langroudi; Fatemeh Kouhkan; Laleh Yazdani; Alireza Nouri Koupaee; Sara Asgharpour; Zahra Shojaei; Taravat Bamdad; Ehsan Arefian
Journal:  Tumour Biol       Date:  2015-04-04

2.  Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Authors:  Dodie Pouniotis; Choon-Kit Tang; Vasso Apostolopoulos; Geoffrey Pietersz
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

3.  Type VI secretion system sheaths as nanoparticles for antigen display.

Authors:  Elena Del Tordello; Olga Danilchanka; Andrew J McCluskey; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

4.  CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil.

Authors:  Ali Keshavarz; Ahmed Alobaida; Ivan F McMurtry; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2019-06-27       Impact factor: 4.939

Review 5.  Guiding principles in the design of molecular bioconjugates for vaccine applications.

Authors:  Haipeng Liu; Darrell J Irvine
Journal:  Bioconjug Chem       Date:  2015-04-16       Impact factor: 4.774

Review 6.  Improvement of different vaccine delivery systems for cancer therapy.

Authors:  Azam Bolhassani; Shima Safaiyan; Sima Rafati
Journal:  Mol Cancer       Date:  2011-01-07       Impact factor: 27.401

7.  Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.

Authors:  Yoshio Fujita; Hiroaki Taguchi
Journal:  Chem Cent J       Date:  2011-08-23       Impact factor: 4.215

8.  CPPsite: a curated database of cell penetrating peptides.

Authors:  Ankur Gautam; Harinder Singh; Atul Tyagi; Kumardeep Chaudhary; Rahul Kumar; Pallavi Kapoor; G P S Raghava
Journal:  Database (Oxford)       Date:  2012-03-07       Impact factor: 3.451

9.  Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis.

Authors:  Kuang-Yuh Chyu; Xiaoning Zhao; Jianchang Zhou; Paul C Dimayuga; Nicole Wm Lio; Bojan Cercek; Noah T Trac; Eun Ji Chung; Prediman K Shah
Journal:  JCI Insight       Date:  2022-06-08

Review 10.  Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery.

Authors:  Suniti Misra; Vincent C Hascall; Ilia Atanelishvili; Ricardo Moreno Rodriguez; Roger R Markwald; Shibnath Ghatak
Journal:  Int J Cell Biol       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.